Anika Therapeutics, Inc.
ANIK
$21.23
$0.552.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 85.85% | 73.56% | 73.89% | 57.00% | 63.95% |
| Total Depreciation and Amortization | 86.15% | -18.80% | -22.36% | 535.93% | 19.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.84% | -52.64% | -69.45% | -63.70% | -69.78% |
| Change in Net Operating Assets | -473.56% | 44.65% | 120.64% | 111.99% | 76.90% |
| Cash from Operations | -4.81% | 19.87% | 107.07% | 9.04% | -29.67% |
| Capital Expenditure | -31.08% | 47.36% | 17.78% | 14.65% | 46.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -100.00% | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -103.67% | 31.77% | 95.19% | 78.50% | 74.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 51.18% | -68.59% | -69.52% | -63.87% | -63.87% |
| Repurchase of Common Stock | -51.40% | -25.38% | -15.20% | -187.32% | -179.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.89% | 2.73% | 17.11% | -51.09% | -363.32% |
| Foreign Exchange rate Adjustments | -1,440.91% | -60.98% | 32.73% | -81.01% | 90.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.82% | 19.05% | 102.05% | 47.14% | -329.30% |